STAT3 and neoplasm: Together, our findings connect Y705-STAT3 activation to the negative regulation of intrinsic HR+/HER2− pro-metastatic properties (CSC, EMT-like) and positive control of functions that can affect the inflammatory/immune milieu at the tumor site (CXCL8, PD-L1 expression).